Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease
Aryeh Fischer(University of Colorado Denver), Jeffrey J. Swigris(National Jewish Health), Richard T. Meehan(National Jewish Health), Kevin K. Brown(Health Protection Surveillance Centre), Tristan J. Huie(National Jewish Health), Evans R. Fernández Pérez(National Jewish Health), Mahalakshmi Krishnamoorthy(National Jewish Health), Gregory P. Cosgrove(National Jewish Health), Stephen K. Frankel(National Jewish Health), Joshua J. Solomon(National Jewish Health), Roland M. du Bois(Imperial College London), Amy L. Olson(National Jewish Health)
Cited by 393
Related Papers
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
|The Lancet|2011|2.1k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
Changes in Clinical and Physiologic Variables Predict Survival in Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2003|762
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2011|713